Regenerative Medical Technology (RMTG) EBIT (2018 - 2026)
Regenerative Medical Technology (RMTG) posted EBIT of $565977.0 for Q2 2026, up 146.31% on a QoQ basis from $229783.0 in Q1 2026, and up 326.31% year-over-year from $132761.2 in Q2 2025.
Powered by 
Analysis
Regenerative Medical Technology (RMTG) EBIT (2018 - 2026) Analysis & Trends
Regenerative Medical Technology has reported EBIT for 9 years, with the latest figure at $565977.0 in Q2 2026.
- On a quarterly basis, EBIT rose 326.31% year-over-year to $565977.0 in Q2 2026; TTM through Jun 2026 was $43725.0, a 84.67% decrease from a year earlier, with the FY2025 full-year figure at -$867162.0, down 1168.18% from the prior year.
- EBIT was $565977.0 for Q2 2026 at Regenerative Medical Technology, up from $229783.0 in the prior quarter.
- The five-year high for EBIT was $565977.0 in Q2 2026, with the low at -$2.5 million in Q4 2022.
- Average EBIT over 5 years is -$235125.3, with a median of -$148385.0 recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: EBIT surged 381.71% in 2024, then slumped 2368.73% in 2025.
- Over 5 years, EBIT stood at -$2.5 million in 2022, then surged by 94.5% to -$135111.0 in 2023, then soared by 381.71% to $380618.0 in 2024, then tumbled by 180.47% to -$306274.0 in 2025, then surged by 284.79% to $565977.0 in 2026.
- The last three EBIT figures came in at $565977.0 (Q2 2026), $229783.0 (Q1 2026), and -$306274.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.31 Bn | 9.47 Bn | 112.79 Mn | 58.42 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | -117.27 Mn |
| 3 | Iovance Biotherapeutics | 3.67 Bn | 3.37 Bn | 55.72 Mn | -51.91 Mn |
| 4 | Legend Biotech | 3.57 Bn | 2.60 Bn | 251.50 Mn | 57.70 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | -52.20 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | -126.55 Mn |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 22.64 Mn |
| 8 | Sarepta Therapeutics | 2.17 Bn | 1.37 Bn | 251.87 Mn | 13.29 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | 434,000.00 |
| 10 | Regenerative Medical Technology | 1.18 Mn | -139,694.93 | 2.58 Mn | 565,977.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 565,977.00 |
| Mar 31, 2026 | 229,783.00 |
| Dec 31, 2025 | -306,274.00 |
| Sep 30, 2025 | -445,761.00 |
| Jun 30, 2025 | -250,087.00 |
| Mar 31, 2025 | 134,960.00 |
| Dec 31, 2024 | 380,618.00 |
| Sep 30, 2024 | 19,648.00 |
| Jun 30, 2024 | -213,981.00 |
| Mar 31, 2024 | -105,105.00 |
| Dec 31, 2023 | -135,111.00 |
| Sep 30, 2023 | -75,063.00 |
| Jun 30, 2023 | -430,841.00 |
| Mar 31, 2023 | -74,211.00 |
| Dec 31, 2022 | -2.46 Mn |
| Sep 30, 2022 | -161,659.00 |
| Jun 30, 2022 | -365,622.00 |
| Mar 31, 2022 | -542,390.00 |
| Dec 31, 2021 | -496,565.00 |
| Sep 30, 2021 | -9.02 Mn |